SCHEMBL7782425

SCHEMBL7782425

C=CCC1(CC=C)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10787509 0.84
SCHEMBL10396189 0.84
SCHEMBL11666029 0.84
SCHEMBL8676646 0.82
SCHEMBL2051155 0.82
SCHEMBL2047338 0.80
SCHEMBL9622258 0.80
SCHEMBL2051063 0.78
SCHEMBL2106822 0.77
SCHEMBL2045083 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891326-B1 NOVEL VITAMIN D ANALOGUES LEO PHARM PROD LTD (DK) 2001-10-04 EP claimed
US-5932565-A Vitamin D analogues Leo Pharmaceutical Products Ltd. A/S (L.o slashed.vens Kemiske Fabrik Produktionsaktieselskab) (DK) 1999-08-03 US claimed
EP-0891326-A1 NOVEL VITAMIN D ANALOGUES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 1999-01-20 EP claimed
WO-1997037972-A1 NOVEL VITAMIN D ANALOGUES Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 1997-10-16 WO claimed
JP-5043566-A None JP disclosed
US-20240110014-A1 SILICONE ELASTOMER FROM SILYLATED POLYSACCHARIDES ROHM AND HAAS COMPANY 2024-04-04 US disclosed
EP-4314119-A1 SILICONE ELASTOMER FROM SILYLATED POLYSACCHARIDES Dow Silicones Corporation (US) 2024-02-07 EP disclosed
US-9718817-B2 Aryl and heteroaryl ether compounds as ROR gamma modulators GLENMARK PHARMACEUTICALS S.A. (CH) 2017-08-01 US disclosed
EP-3131880-A1 ARYL AND HETEROARYL ETHER COMPOUNDS AS ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2017-02-22 EP disclosed
US-20170022195-A1 ARYL AND HETEROARYL ETHER COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-01-26 US disclosed
WO-2015159233-A1 ARYL AND HETEROARYL ETHER COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-10-22 WO disclosed
EP-0891326-B1 NOVEL VITAMIN D ANALOGUES LEO PHARM PROD LTD (DK) 2001-10-04 EP disclosed
US-5932565-A Vitamin D analogues Leo Pharmaceutical Products Ltd. A/S (L.o slashed.vens Kemiske Fabrik Produktionsaktieselskab) (DK) 1999-08-03 US disclosed
EP-0891326-A1 NOVEL VITAMIN D ANALOGUES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 1999-01-20 EP disclosed
WO-1997037972-A1 NOVEL VITAMIN D ANALOGUES Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 1997-10-16 WO disclosed
EP-0656365-B1 Substituted 2beta-morpholinoandrostane derivatives AKZO NOBEL NV (NL) 1997-04-09 EP disclosed
US-5593983-A PREPARATION BY REACTING SUBSTITUTED /THIO/MORPHOLINE OR SALT AND 2,3-EPOXYANDROSTANE OR 2,3-EPOXY-19-NOR-ANDROSTANE; USE TO INDUCE ANESTHESIA AKZO NOBEL N.V. (NL) 1997-01-14 US disclosed
EP-0656365-A1 Substituted 2beta-morpholinoandrostane derivatives Akzo Nobel N.V. (NL) 1995-06-07 EP disclosed
JP-H0543566-A OPTICALLY ACTIVE COMPOUND AND LIQUID CRYSTAL COMPOSITION MITSUBISHI RAYON CO LTD 1993-02-23 JP disclosed